Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 92

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 8
Chunk 92
---
 the nine months ended September 30, 2025Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$4 $1 $— $— $— Effects of cash flow hedges4 1 — — — Cross-currency swaps— — — 25 — Foreign currency forward and options contracts— — — 15 — Effects of net investment hedges(1)— — — 39 — Interest rate swaps(2)— — — 83 — Debt basis adjustment on Long-term borrowings— — — (96)— Effects of fair value hedges— — — (13)— Foreign currency forward contracts48 12 — — (2)Other derivatives(3)— — 4 — 4 Effects of derivatives not designated as hedging instruments48 12 4 — 2 For the nine months ended September 30, 2024Cost of productsCost of servicesSG&AInterest and other financial charges – netOther(4)Foreign currency forward contracts$3 $1 $— $— $— Effects of cash flow hedges3 1 — — — Cross-currency swaps— — — 24 — Foreign currency forward and option contracts— — — 8 — Effects of net investment hedges(1)— — — 32 — Interest rate swaps(2)— — — 11 — Debt basis adjustment on Long-term borrowings— — — (31)— Effects of fair value hedges— — — (21)— Foreign currency forward contracts21 5 — — — Other derivatives(3)— — 7 — 28 Effects of derivatives not designated as hedging instruments21 5 7 — 28 (1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three and nine months ended September 30, 2025 and 2024.(2) Amount includes interest expense on interest rate derivatives of $(5) million and $(7) million for the three months ended September 30, 2025 and 2024, respectively, and $(13) million and $(21)